Filing Details
- Accession Number:
- 0001232524-16-000281
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-26 17:02:42
- Reporting Period:
- 2016-05-24
- Filing Date:
- 2016-05-26
- Accepted Time:
- 2016-05-26 17:02:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1536639 | Seamus Mulligan | Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2016-05-24 | 1,400 | $148.65 | 1,101,179 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2016-05-24 | 11,888 | $149.64 | 1,089,291 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2016-05-24 | 9,954 | $150.72 | 1,079,337 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2016-05-24 | 4,726 | $151.51 | 1,074,611 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.18 to $149.14. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.18 to $150.17. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $150.18 to $151.17. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $151.18 to $151.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Billionaire Hedge Funds
